John Duncan Higgons Jounce Therapeutics, Inc. (JNCE) insider trading activity

JNCE Quotes by TradingView

John Duncan Higgons is Director of Jounce Therapeutics, Inc.. Currently has a direct ownership of 9,713 shares of JNCE, which is worth approximately $0. The most recent transaction as insider was on Apr 15, 2021, when has been sold 200 shares (Common Stock) at a price of $10.0 per share, resulting in proceeds of $2,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.71K
0% 3M change
0% 12M change
Total Value Held $0

John Duncan Higgons Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 15 2021
SELL
Open market or private sale
$2,000 $10.0 p/Share
200 Reduced 2.02%
9,713 Common Stock
Mar 15 2021
SELL
Open market or private sale
$2,560 $12.8 p/Share
200 Reduced 1.98%
9,913 Common Stock
Feb 16 2021
SELL
Open market or private sale
$2,356 $11.78 p/Share
200 Reduced 1.94%
10,113 Common Stock
Jan 21 2021
SELL
Open market or private sale
$2,222 $11.11 p/Share
200 Reduced 1.9%
10,313 Common Stock
Jan 20 2021
SELL
Open market or private sale
$18,000 $12.0 p/Share
1,500 Reduced 12.49%
10,513 Common Stock
JDH

John Duncan Higgons

Director
Cambridge, MA

Track Institutional and Insider Activities on JNCE

Follow Jounce Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JNCE shares.

Notify only if

Insider Trading

Get notified when an Jounce Therapeutics, Inc. insider buys or sells JNCE shares.

Notify only if

News

Receive news related to Jounce Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on JNCE